Saarinen et al. demonstrated that both high-and low-Gleason grade tumors expressed ASCT2 in patients with CSPC and histologically confirmed PCa who underwent PET/CT before prostatectomy [24]. This evidence concerns the gene SLC1A5 and posterior cortical atrophy.